Rural Smoking Cessation

Part of paid clinical trials in Minneapolis, Minnesota.

Sponsor
Masonic Cancer Center, University of Minnesota
Study ID
NCT06584929
Status
Recruiting
Apply to this trial

Conditions

  • Smoking Cessation

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Nicoderm CQ nicotine patch — DRUG
    Two week supply provided to participants on study.
  • Nicorette Nicotine Lozenges — DRUG
    Two week supply provided to participants on study.

Study Details

Understanding ways to help people who live in rural areas quit smoking is a public health priority. quitting smoking among rural people who smoke is a critical public health concern. People in rural areas smoke at higher rates than those in urban areas, experience high rates of smoking caused cancers and deaths. We are recruiting rural people from around the country to better understand how different quit smoking methods can improve a person's chances of successfully quitting smoking.

Key Dates

Start date
Mar 17, 2026
Status verified
Jun 2026
Primary completion
Oct 1, 2028
Completion
Aug 31, 2029

Study Design

Enrollment
272 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Intervention Condition
    Weekly text and email messages referring to Smokefree.gov, NRT Starter kit, free 2-week supply of patches (Nicoderm CQ in either 21 or 14 mg nicotine) and lozenges (Nicorette Nicotine Lozenges, Mint Flavor in either 4 or 2 mg nicotine) with NRT education plus referral to where to request more NRT.
  • No Intervention: Control Condition
    Weekly text and email messages referring to Smokefree.gov
  • No Intervention: RHE - Intervention Condition
    Weekly text and email messages on reduced harm or exposure (RHE) tobacco products.

Primary Outcome Measure

Number of participants abstinent from all combustible tobacco products [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Masonic Cancer CenterMinneapolisMinnesota55455
Dana Carroll, PhD, MPH
[email protected]
612-624-4610

Find similar trials in Minneapolis, MN

By research site
Masonic Cancer Center· Minneapolis, MN

Related Studies